Abstract:INTRODUCTION:Pancreatic cancer is a lethal disease with a very poor prognosis. This study investigates survival of patients diagnosed with metastatic pancreatic cancer (mPC) based on local treatment of the primary tumor. METHODS:Patients diagnosed with stage IV mPC between 2004 and 2013 were identified from the Surveillance, Epidemiology and End Results (SEER) database. Cancer-specific survival (CSS) and overall survival (OS) were examined. CSS and OS were examined by using the Kaplan-Meier method with the log-rank test. Multivariable survival analyses of CSS and OS were conducted using the Cox proportional hazard model. RESULTS:A total of 28918 patients with mPC were included in this analysis. There were 467 patients who received surgical resection (1.6%) and 28451 patients who did not (98.4%). Patients who were younger than 70 years (odds ratio [OR]=1.45, 95% CI=1.04-2.03, p=0.03), diagnosed from 2004 to 2008 (OR=1.49, 95% CI=1.25-1.80, p<0.001), female (OR=1.31, 95% CI=1.08-1.58, p<0.001), married (OR=1.56, 95% CI=1.27-1.90, p<0.001), at T3 stage (OR=3.53, 95% CI=1.10-11.37, p=0.035), at N1 stage (OR=2.05, 95% CI=1.68-2.50, p<0.001), presenting histological types other than adenocarcinoma (OR=2.04, 95% CI=1.43-2.94, p<0.001), and with tumor of the pancreatic head (OR=1.90, 95% CI=1.27-2.82, p=0.002) were more likely to be treated with surgical resection. The results of multivariate analysis showed that surgical resection of the primary tumor was associated with CSS (hazard ratio [HR]=0.58, 95% CI=0.52-0.64, p<0.001) and OS (HR=0.59, 95% CI=0.53-0.65, p<0.001) benefits. In addition, not receiving chemotherapy (HR=2.33, 95% CI=2.27-2.39, p<0.001), age >50 years (HR=1.25, 95% CI=1.09-1.42, p=0.001), male (HR=1.121, 95% CI=1.09-1.15, p<0.001), black ethnicity (HR=1.11, 95% CI=1.1-1.15, p<0.001), unmarried (HR=1.20, 95% CI=1.17-1.23, p<0.001), histological type of adenocarcinoma (HR=1.18, 95% CI=1.14-1.22, p<0.001), and primary site other than the pancreatic head (HR=1.08, 95% CI=1.05-1.11, p<0.001) are factors associated with poor survival. CONCLUSION:This study reveals that local treatment has the primary benefit of both CSS and OS in patients with mPC. These results may guide the management of this patient population.

Surgical outcome of a resectable primary cancer of pancreas associated with another synchronous/metachronous resectable primary malignant tumor: a report of 13 patients and review of the literature

[Inquire into Factors Influencing Recurrence Following Resection of Carcinoma of the Head of Pancreas].

Management of Primary Squamous Cell Carcinoma of the Pancreas: A Case Report.

Risk Factors Influencing Recurrence Following Resection of Pancreatic Head Cancer.

The feasibility of surgical resection for carcinoma of the head of pancreas with major vascular invasion

Surgical Resection of a Primary Tumor Improves Survival of Metastatic Pancreatic Cancer: a Population-Based Study.

Surgical Treatment of Pancreatic Cancer: a Follow-Up Study in 216 Cases

Do Patients Diagnosed with Metastatic Pancreatic Cancer Benefit from Primary Tumor Surgery? A Propensity-Adjusted, Population-Based Surveillance, Epidemiology and End Results (SEER) Analysis

The Prognostic Impact of Primary Tumor Resection in Pancreatic Neuroendocrine Tumors with Synchronous Multifocal Liver Metastases.

Clinical Efficacy of the Laparoscopic Resection for Pancreatic Neuroendocrine Neoplasms

Short- and Long-Term Outcomes of Laparoscopic Organ-Sparing Resection for Pancreatic Neuroendocrine Neoplasms

Resection for Advanced Carcinoma of Pancreatic Head

Surgical Resection for Metastatic Tumors in the Pancreas: A Single-Center Experience and Systematic Review.

Is Surgery Feasible and Safe? A Single-Center Experience in a High-Volume and Certified Pancreatic Surgery Center in Germany

Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?

Time to Think: Selecting Patients Who May Benefit from Synchronous Resection of Primary Pancreatic Cancer and Liver Metastases

Surgical resection or palliative care for pancreatic cancer with liver oligometastasis

Surgical Resection and Outcome of Pancreatic Cystic Neoplasms in China: Analysis of a 16-Year Experience from a Single High-Volume Academic Institution

Curative Resection of Pancreatic Head Carcinoma in Recent 30 Years: Report of 377 Cases.

Resection of rectal metastasis after previous radical surgery for pancreatic cancer: Case report and literature review

Surgical Resection of Primary Tumor Improves Survival of Pancreatic Neuroendocrine Tumor with Liver Metastases.